Fig. 4From: Glycemic outcomes of Advanced Hybrid Closed Loop system in children and adolescents with Type 1 Diabetes, previously treated with Multiple Daily Injections (MiniMed 780G system in T1D individuals, previously treated with MDI)Glucose targets and Active insulin time during AHCL system at baseline and at end of the study. Values are shown as % of participants. AHCL, Advanced Hybrid Closed Loop SystemBack to article page